David Badcock, CEO of Drug Science
For episode 36 of the Professionally Cannabis Podcast, the hosts welcomed David Badcock, CEO at Drug Science. As CEO of the charity spearheading Project Twenty21 – the initiative aiming to get cannabis medicine to 20,000 patients in the UK – David explores the UK cannabis landscape, the team behind Drug Science, and other projects around alcohol and psychedelics.
Check out other podcasts on the GCI Content Hub by clicking here.
